Skip to main content
Search

Drexel University

4 related articles

Subscribe to updates
  1. A personal reference curve for brain wiring: BRIDGE cuts brain-age error by 3%–9% and ties deviation scores to ADOS in autistic boys

    Brain-connectivity differences in autism and other neurodevelopmental disorders have mostly been read from group-average case-control contrasts, which flatten individual variation. BRIDGE combines a graph variational autoencoder with normative modeling to learn an age-varying reference trajectory of structural connectomes from 1,164 neurotypical participants, then reports a global deviation score from brain-age difference and an individualized regional deviation map from regional embeddings. In 229 autistic children, the global score correlated with ADOS (Spearman R=−0.291) and IQ (Pearson R=0.195) in males, and brain-age prediction error was 3%–9% lower than comparable deep-learning models.

  2. arXiv

    ProbeGuard certifies abstention from how medical LLM consensus forms, answering 55.3% of the MedQA unanimous layer at 9.0% observed risk

    The work introduces ProbeGuard, a certified abstention framework that decides from how multi-round consensus formed rather than from terminal agreement: it derives trajectory features from the system's execution log, checks unanimous first-round votes with rationale semantic entropy and an active counter-evidence probe, and converts these scores into a distribution-free selective-risk bound via stratified Learn-then-Test calibration; on MedQA terminal agreement scores 0.512 AUROC while the process score reaches 0.696, and 13.4% of unanimous votes are wrong, with the certified rule answering 55.3% of that layer at 9.0% observed risk.

  3. Loss or blockade of myeloid TLR2 improves survival and reduces neutrophils and lung inflammation in influenza-infected neonatal mice

    Combining human cord blood monocytes with a neonatal mouse influenza model, this study found that neonatal monocytes sustain higher TLR2 expression after LTA or IAV stimulation, while TLR2 gene deletion, anti-TLR2 antibody blockade, or myeloid-specific TLR2 deletion improved survival of IAV-infected neonatal mice (for example, 61% versus 25% survival for TLR2−/− versus wild-type neonates, and 46% versus 7% with anti-TLR2 antibody), accompanied by reduced neutrophils at 6 days post-infection, lower histopathology scores in myeloid conditional knockouts, and no further rise in IL-6, TNF-α, MCP-1, CXCL1, and CXCL2 from 3 to 6 days post-infection, suggesting that myeloid TLR2 signaling exacerbates neonatal susceptibility to respiratory viral infection by amplifying pulmonary inflammation.

  4. arXiv

    BioGait-VLM reaches 68.1% accuracy on an 8-class gait benchmark and is chosen as the better model in 69.2% of blinded expert cases

    The work proposes BioGait-VLM, a tri-modal (RGB vision, language, explicit biomechanics) framework built on a frozen InternVL3.5-1B, combining a Temporal Evidence Distillation branch with a Biomechanical Tokenization branch that projects 3D skeleton kinematics into language-aligned semantic tokens; on a subject-disjoint 8-class benchmark of 1,181 clips formed by merging public GAVD with a newly collected 30-patient degenerative cervical myelopathy (DCM) cohort, it reaches 68.1% accuracy and 52.9% macro F1 (98.1% F1 on DCM, 80.4% on Abnormal gait), and in a blinded review of 52 held-out clips four DCM-domain experts selected it as superior in 69.2% of cases (36/52, p<0.001).

You’re all caught up